
Opinion|Videos|December 23, 2024
Symptoms Management and Targeting the Root Cause of IgAN
Key Takeaways
- Biomarkers, including genetic mutations and protein expressions, are vital for predicting disease progression and treatment response.
- Advanced diagnostic techniques are essential for identifying molecular and cellular indicators that inform patient prognosis.
Panelists discuss how clinicians can effectively shift treatment strategies for IgA nephropathy from merely managing symptoms to actively targeting the root causes of the disease.
Advertisement
Episodes in this series

- Please discuss how clinicians can shift the treatment strategy between managing symptoms and targeting the root cause of the disease.
Advertisement
Advertisement
Advertisement
Trending on HCPLive
1
RAINIER: Povetacicept Cuts Proteinuria, Gd-IgA1 in IgA Nephropathy
2
Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD
3
Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD
4
IMAgINATION: Sefaxersen Meets Phase 3 Proteinuria Endpoint in IgA Nephropathy
5

